Invention Grant
- Patent Title: Non-nucleoside reverse transcriptase inhibitors
- Patent Title (中): 非核苷逆转录酶抑制剂
-
Application No.: US10719369Application Date: 2003-11-21
-
Publication No.: US07642277B2Publication Date: 2010-01-05
- Inventor: Bruno Simoneau , Anne-Marie Faucher , Serge Landry , Jeffrey O'Meara , Bounkham Thavonekham , Christiane Yoakim
- Applicant: Bruno Simoneau , Anne-Marie Faucher , Serge Landry , Jeffrey O'Meara , Bounkham Thavonekham , Christiane Yoakim
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Mary-Ellen M. Devlin; Alan R. Stempel
- Main IPC: A61K31/43
- IPC: A61K31/43 ; A61K31/44 ; C07D257/00 ; C07D401/00

Abstract:
Disclosed herein are compounds of formula Ar1—X—W—Ar2 wherein Ar1 and Ar2 represent aryl groups characterized generally as aromatic heterocycles (e.g. imidazolyl or tetrazolyl) or carbocycles (e.g. phenyl or naphthalenyl); the aryl groups are optionally substituted or fused with other heterocycles or carbocycles; the aryl groups can bear substituents such as alkyl, halo or O-alkyl. X is a heteroatom, a valence bond or an optionally substituted divalent methylene, and W represents a spacer; typical spacers include divalent alkylene or alkylene-amido, -amido or -oxy radicals, which may optionally be substituted (e.g. hydroxyl or oxo). A typical compound is a derivative of 2-(N-napthalenyltetrazolylthio)-N-(2-nitrophenyl)acetamide. The compounds have inhibitory activity against Wild Type and single or double mutant strains of HIV.
Public/Granted literature
- US20050054639A1 Non-nucleoside reverse transcriptase inhibitors Public/Granted day:2005-03-10
Information query
IPC分类: